Article Information
History
- April 8, 2020.
Article Versions
- You are currently viewing Version 1 of this article (April 8, 2020 - 04:00).
- Version 2 (April 15, 2020 - 09:30).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brian Fulton-Howarda,
- Alison M. Goatea,
- Robert P. Adelsonb,
- Jeremy Koppelb,c,d,
- Marc L. Gordonb,d,
- Alzheimer’s Disease Genetics Consortium,
- Nir Barzilaie,
- Gil Atzmone,f,
- Peter Daviesb,d and
- Yun Freudenberg-Huab,c,d,*
- aRonald M. Loeb Center for Alzheimer’s disease, Department of Neuroscience, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, New York 10029
- bLitwin-Zucker Center for Alzheimer’s Disease, The Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, New York 11030
- cDivision of Geriatric Psychiatry, Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, New York 11004
- dDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, 500 Hofstra Boulevard, Hempstead, New York 11549
- eInstitute for Aging Research, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461
- fFaculty of Natural Sciences, University of Haifa, Abba Hushi Boulevard, Mount Carmel, Haifa 3498838, Israel
- ↵*Corresponding Author:
Yun Freudenberg-Hua, MD, Litwin Zucker Alzheimer’s Research Center, the Feinstein Institutes for Medical Research, 350 Community Drive, Manhasset, New York 11030, United States (yfreuden{at}northwell.edu)
Posted April 08, 2020.
Effect of Polygenic Score on Alzheimer’s Disease Risk Depends on Age and APOE Status
